Is Trump pushing FDA approval for this new breakthrough?

Will this new technology save us from the next COVID-19?
 ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌   ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ ‌ 

Dear Friend,

Imagine grabbing your smartphone tomorrow morning...

And before you check your email or read the headlines, you hold your phone to your eye for a quick scan.

Within seconds, you're told the exact state of your health. It will detect if you're infected with the latest scary virus, or the common cold...long before you notice a fever.

Your morning scan can catch tiny changes to a cell is the beginning of cancer...years before you notice a single symptom. Or spot an undetectable tremor in your eye that's an early warning sign of Parkinson's.

Sounds like science fiction, right? But it's much closer than you think.

This innovative technology is being tested as we speak and has just received the FDA's rare "Breakout Device Designation." This means it's been fast-tracked for approval.

So the company behind it gets to cut through the normal red tape and get this powerful breakthrough to market faster.

Very soon this breakout technology will be on every smartphone, tablet, laptop and desktop.

I have the name of the little-known $4 stock behind this breakthrough. And you'll want to know it, too—before that FDA approval comes through.

Because I have seen stocks rise 1,000% or close to it in a single day with FDA approval.

And I think that's just the beginning.

Because this stock belongs to an elite group of stocks called "disruptors" that have seen historic gains of 2,694%, 15,295%, 34,340%...even 130,376%.

I'll explain everything in a brand-new report I've just released.

Just click here to read it now.

You'll get the exciting details about this breakout technology poised for FDA approval any day now...and how you can get into this $4 stock before the huge price runup begins.

But you must act quickly. Get the details now.

Sincerely,

Stephen McBride
Stephen McBride
Chief Analyst, RiskHedge

This is a PAID ADVERTISEMENT provided to customers of Schaeffer's Investment Research. Although we have sent you this email, Schaeffer's does not specifically endorse this product nor is it responsible for the content of this advertisement. Furthermore, we make no guarantee or warranty about what is advertised above.

Your privacy is very important to us, if you wish to be excluded from future notices, do not reply to this message. Instead, please click here.

Schaeffer's Investment Research
5151 Pfeiffer Road, Suite 250
Cincinnati, Ohio 45242

Privacy Policy

No comments:

Post a Comment